Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)

NCT03689842 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT03689842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03689842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Recruiting
Start date
December 14, 2017
Completion date
December 14, 2034
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mayer rokitansky kuster hauser syndrome